The value of patent term extensions to the pharmaceutical industry in the USA

Journal of Generic Medicines

Volumn 5, Issue 3, 2008, Pages 201-208

  Clift, Charles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMFEBUTAMONE; AMLODIPINE BESYLATE; ARIPIPRAZOLE; ATORVASTATIN; CLOPIDOGREL; ENOXAPARIN; ESCITALOPRAM; ESOMEPRAZOLE; ETANERCEPT; FLUTICASONE PROPIONATE PLUS SALMETEROL; INFLIXIMAB; LANSOPRAZOLE; MONTELUKAST; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OLANZAPINE; ORPHAN DRUG; PANTOPRAZOLE; PIOGLITAZONE; QUETIAPINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISPERIDONE; RITUXIMAB; ROSIGLITAZONE; SERTRALINE; SIMVASTATIN; UNINDEXED DRUG; VENLAFAXINE; ZOLPIDEM TARTRATE;

ARTICLE; DRUG APPROVAL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; ECONOMIC ASPECT; EXPIRATION DATE; FOOD AND DRUG ADMINISTRATION; MEDICAL TECHNOLOGY; PATENT; UNITED STATES;

EID: 42449105195     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2008.6     Document Type: Article

References (8)

1. Federal Register (200W): 72(36), 8183. http:www.gpoaccess.gov/fr/ index.html, accessed 15th February 2008.
2. IMS website (2006): www.imshealth.com/ims/portal/front/indexC/ 0,2773,6025_5264_0,00.html, accessed latter half of 2006.
3. USPTO website (2008): www.uspto.gov/web/offices/pac/dapp/opla/term/ 156.html, accessed on 3rd February, 2008.
4. FDA website (2008): http://www.fda.gov/cder/rdmt/InternetNDA05.htm; http://www.fda.gov/cder/rdmt/InternetNDA06.htm; http://www.fda.gov/cder/ rdmt/InternetNDA07.htm; http://www.fda.gov/cder/rdmt/pstable.htm, all accessed on 3rd February, 2008.
5. FDA website (2007): www.fda.gov/cder/ob/, accessed 10th August, 2007.
6. FDA website (2007): www.fda.gov/cder/pediatric/exgrant.htm, accessed 15th February 2008.
7. FDA website (2007): http://www.fda.gov/orphan/designat/allap.rtf, last updated on 3rd October, 2007, accessed 15th February 2008.
8. Singh, A., Gilbert, J. & Henske, P. (2003). Rebuilding big pharma's business model. Windhover Information 21, 1-10. http://www.bain.com/bainweb/PDFs/cms/Public/rebuilding_big_pharma.pdf, accessed 15th February 2008.